mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.3 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.032 |
0.3 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.052 |
0.3 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.3 |
mRNA |
Bortezomib |
FIMM |
pan-cancer |
AAC |
0.15 |
0.3 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |